Announced Sat, 8 Aug · 16:46 IST
Q1 FY27 earnings call: revenue up 5%, margin expansion guided
Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsCfo Debt Reduction RoadmapInvestor Communications View source PDFExplain this filing
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.0%1-day move
₹166.15
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.0-5.9-7.8-5.9-1.2+3.6————
Up moveDown movePending
AI summary
Q1 FY27 revenue grew 5% YoY to INR69 cr with EBITDA margin at 22%. SteriPort contributes 44% of revenue. SteriPort Line 3 (12 crore bottles per year) to commission by Aug 25 after FDA approval; peak revenue potential INR110-120 cr. SVP facility expected by Mar 2027. 10.8 MW captive solar plant commissioned Jun 26, saving INR9 cr. Management guided FY28 revenue of INR425 cr and EBITDA margin of 25-26%.
Likely market impact
Capacity expansion to drive revenue to INR425 cr in FY28 with margin expansion to 25-26%, supporting earnings growth.